Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis drug combination Tafinlar + Mekinist receives EU approval for BRAF V600-positive advanced N

cphi-onlineApril 05, 2017

Tag: NSCLC , Novartis

PharmaSources Customer Service